Wednesday, November 15, 2006

Vanda Reports Positive Test Results

Vanda Pharmaceuticals Inc. (VNDA) reported positive test results for its insomnia treatment VEC-162 sending the stock price soaring $5.14 to close at $14.90.

0 Comments:

Post a Comment

<< Home